Neuberger Berman Group LLC Global Blood Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $8.89 Million - $15.1 Million	-236,158 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $105,520 - $148,980	2,000 Added 0.85%	236,158 $13 Million
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $9.22 Million - $15.5 Million	189,158 Added 420.35%	234,158 $14.8 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $104,258 - $217,912	2,499 Added 5.88%	45,000 $2.3 Million
Q4 2019 Feb 12, 2020	SELL	$45.7 - $81.86 $1.26 Million - $2.25 Million	-27,499 Reduced 39.28%	42,501 $3.38 Million

Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $761,880 - $972,888	-16,800 Reduced 19.35%	70,000 $3.4 Million
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $1.86 Million - $2.23 Million	35,300 Added 68.54%	86,800 $4.57 Million
Q1 2019 May 13, 2019	BUY	$39.99 - $53.48 $639,840 - $855,680	16,000 Added 45.07%	51,500 $2.73 Million
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $883,120 - $1.31 Million	28,000 Added 373.33%	35,500 $1.46 Million
Q2 2018 Aug 13, 2018	SELL	$38.7 - $50.15 $301,860 - $391,170	-7,800 Reduced 50.98%	7,500 $339,000
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $285,120 - $474,480	-7,200 Reduced 32.0%	15,300 $739,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $668,250 - $1.03 Million	22,500	22,500 $885,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.